This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugsdeveloped by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT.
While the specific agenda may have varied, here are some of the main tracks and topics that were likely covered: Main Tracks: AI and Machine Learning: Discussions on the applications of AI and ML in drug discovery, medical imaging, and personalised medicine. Regulatory Landscape: Changes in healthcare regulations and policies.
Consolidation in Specific Segments: M&A activity will be concentrated in areas like telemedicine, medical devices, and health IT. Specific predictions for 2025: AI-powered drug discovery: A major pharmaceutical company may acquire a European AI-driven drug discovery startup to accelerate its pipeline development.
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.
Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface. We understand how vital it is for outcomes and look forward to working with the Redi.Health team through its next phase of growth.”.
Remote patient monitoring technologies are akin to telemedicine technologies, since they automatically observe and report on patients, often with chronic illnesses, so caregivers can remotely keep tabs on patients. The platform also is designed for direct-to-patient telemedicine.
Desperate for medical insights without delay, researchers, pharmaceutical companies and government agencies turned to health information captured through real-world data sources. A new medication is introduced to the market via legislation rather than through formal drugdevelopment practices (3); 3. PNAS Nov 2020; vol.
Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Examples: CVS Health acquiring telemedicine provider Aetna, Ascension acquiring teleICU company Aidiant.
Mike King, Senior Director, Product and Strategy at IQVIA Increasing integration between quality, regulatory, and safety teams in pharmaceutical companies as well as the existing strong integrations in these departments in MedTech and IVD organizations.
But AI investments will shift over the next two years to prioritize telemedicine (38%), robotic tasks such as process automation (37%) and delivery of patient care (36%), the survey found. Clinical trials and diagnosis rounded out the top five investment areas. Companies also have leveraged AI to help with clinical trial site selection.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content